Roche Molecular Systems Senior Developer Salaries in Coeur D Alene, ID
The average Roche Molecular Systems Senior Developer in Coeur D Alene, ID earns an estimated $158,401 annually, which includes an estimated base salary of $134,928 with a $23,473 bonus. Roche Molecular Systems' Senior Developer compensation is $20,806 more than the US average for a Senior Developer. Senior Developer salaries at Roche Molecular Systems in Coeur D Alene, ID can range from $52,000 - $500,000.
In Coeur D Alene, ID, The Engineering Department at Roche Molecular Systems earns $9,310 more on average than the Design Department. Comparably data has a total of 1 salary record from Roche Molecular Systems Senior Developers.
Last updated 2 years ago.
- $134,928
- avg. base
- $23,473
- avg. bonus
Senior Developer Salaries at Roche Molecular Systems
In Coeur D Alene, ID, Senior Developers earn $4,543 more than Senior Developers, and $7,666 less than Principal Engineers.
Compensation at Roche Molecular Systems by Department
In Coeur D Alene, ID, The Engineering Department averages $9,310 more than the Design Department, and $5,243 less than the Business Development Department
Recent Senior Developer Salaries at Roche Molecular Systems
Senior Developer Compensation by Gender (All Companies)
The average female Senior Developer at companies similar size to Roche Molecular Systems reported making $146,554, while the average male Senior Developer at similar sized companies reported making $156,665.
Senior Developer Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Senior Developer at companies similar size to Roche Molecular Systems reported making $153,064, while the average Native American Senior Developer at similar sized companies reported making $101,264.
How Senior Developers at Roche Molecular Systems Rate Their Compensation
The majority of Senior Developers at Roche Molecular Systems believe they're compensated fairly. 100% of Senior Developers at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
